BOLT
Price
$0.41
Change
-$0.03 (-6.82%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
15.77M
15 days until earnings call
SCPX
Price
$0.16
Change
-$0.01 (-5.88%)
Updated
Mar 10, 04:58 PM (EDT)
Capitalization
961.33K
Ad is loading...

BOLT vs SCPX

Header iconBOLT vs SCPX Comparison
Open Charts BOLT vs SCPXBanner chart's image
Bolt Biotherapeutics
Price$0.41
Change-$0.03 (-6.82%)
Volume$900
Capitalization15.77M
SCORPIUS HOLDINGS
Price$0.16
Change-$0.01 (-5.88%)
Volume$1.3K
Capitalization961.33K
BOLT vs SCPX Comparison Chart
Loading...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLT vs. SCPX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLT is a Hold and SCPX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (BOLT: $0.44 vs. SCPX: $0.17)
Brand notoriety: BOLT and SCPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLT: 217% vs. SCPX: 32%
Market capitalization -- BOLT: $15.77M vs. SCPX: $961.33K
BOLT [@Biotechnology] is valued at $15.77M. SCPX’s [@Biotechnology] market capitalization is $961.33K. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLT’s FA Score shows that 1 FA rating(s) are green whileSCPX’s FA Score has 1 green FA rating(s).

  • BOLT’s FA Score: 1 green, 4 red.
  • SCPX’s FA Score: 1 green, 4 red.
According to our system of comparison, both BOLT and SCPX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLT’s TA Score shows that 3 TA indicator(s) are bullish while SCPX’s TA Score has 4 bullish TA indicator(s).

  • BOLT’s TA Score: 3 bullish, 4 bearish.
  • SCPX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both BOLT and SCPX are a bad buy in the short-term.

Price Growth

BOLT (@Biotechnology) experienced а -8.11% price change this week, while SCPX (@Biotechnology) price change was -2.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

BOLT is expected to report earnings on May 08, 2025.

SCPX is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BOLT($15.8M) has a higher market cap than SCPX($961K). BOLT YTD gains are higher at: -18.520 vs. SCPX (-49.697). SCPX has higher annual earnings (EBITDA): -22.84M vs. BOLT (-70.51M). BOLT has more cash in the bank: 53.8M vs. SCPX (4.81M). SCPX has less debt than BOLT: SCPX (14.9M) vs BOLT (18.2M). SCPX (10M) and BOLT (9.78M) have equivalent revenues.
BOLTSCPXBOLT / SCPX
Capitalization15.8M961K1,644%
EBITDA-70.51M-22.84M309%
Gain YTD-18.520-49.69737%
P/E RatioN/AN/A-
Revenue9.78M10M98%
Total Cash53.8M4.81M1,119%
Total Debt18.2M14.9M122%
FUNDAMENTALS RATINGS
SCPX: Fundamental Ratings
SCPX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLTSCPX
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
71%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
70%
Bullish Trend 26 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
69%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLI82.062.52
+3.17%
Mueller Industries
VLYPP25.000.01
+0.04%
Valley National Bancorp
LSEA7.22-0.19
-2.56%
Landsea Homes Corp
CNTA16.23-0.53
-3.16%
Centessa Pharmaceuticals plc
CTM1.22-0.04
-3.17%
Castellum

BOLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLT has been loosely correlated with VRPX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLT jumps, then VRPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
-3.11%
VRPX - BOLT
47%
Loosely correlated
+3.48%
SCPX - BOLT
33%
Loosely correlated
-0.36%
CYTK - BOLT
33%
Loosely correlated
+0.37%
ELEV - BOLT
31%
Poorly correlated
-0.02%
ORMP - BOLT
30%
Poorly correlated
+9.36%
More

SCPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPX has been loosely correlated with SPRB. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPX jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPX
1D Price
Change %
SCPX100%
-0.36%
SPRB - SCPX
43%
Loosely correlated
-1.73%
FENC - SCPX
39%
Loosely correlated
+1.03%
VRPX - SCPX
37%
Loosely correlated
+3.48%
ALVR - SCPX
34%
Loosely correlated
+1.44%
OVID - SCPX
34%
Loosely correlated
+0.17%
More